Untitled

Nasal packing is a fundamental component of otolaryngologic (ENT) practice, widely used for the management of epistaxis and postoperative care following procedures such as septoplasty, turbinate reduction, functional endoscopic sinus surgery (FESS), and rhinoplasty.1 By providing mechanical support, facilitating haemostasis, and protecting healing tissues, nasal packing helps reduce postoperative complications and improve patient recovery.

Today, a variety of nasal packing materials are available, including resorbable nasal packing, inflatable devices, ribbon gauze, and self-expanding polyvinyl alcohol (PVA)-based nasal pack such as SURGI-PVA™. Each type is designed to address specific clinical needs, ranging from haemostasis to improved patient comfort.

In this blog, we’ll explore different types of nasal packing for nose bleeding and how they help manage bleeding, support healing, and aid recovery after nasal procedures.

When Is Nasal Packing Commonly Used?

What Are the Different Types of Nasal Packing?

Why Is Nasal Packing Important in Nasal Surgery?

For each of these surgeries, the selection of nasal wound dressings is critical to achieving the desired outcomes. Effective nasal packing helps manage bleeding, supports the structural integrity of the nose, prevents adhesion and infection, and enhances overall comfort.1

Clinical Evidence for Nasal Packing

Clinical evidence supports the use of a wide range of nasal packing materials, from absorbable options such as Cutanplast®, MeroGel®, CMC Foam, Nasopore®, and Spongostan® to non-absorbable materials like Merocel® (PVA packs) have demonstrated clinical benefits.1–5

External Dacrocystorhinostomy (RCT, n=41): Absorbable gelatin sponge packing reduced postoperative bleeding and improved haemostasis and anatomical success rates compared with xylocaine- and adrenaline-soaked gauze.5

Epistaxis (n=127): PVA nasal packing is a proven first-line treatment for epistaxis, achieving successful bleeding control in 91.5% of patients. Its ease of insertion, rapid application, and reliable haemostatic performance make it a widely used option in routine clinical practice. PVA nasal packing is an effective form of first-line treatment in patients with epistaxis.6

Functional Endoscopic Sinus Surgery (FESS) (Prospective, RCT, n=41): Levobupivacaine-soaked PVA sponge packs significantly reduced postoperative pain and improved patient comfort compared with saline-soaked PVA packs. The study found that levobupivacaine-soaked PVA packing is a simple, effective, and well-tolerated method for managing pain following FESS7

Tonsillectomy (A cross-sectional prospective study, n=211): ORC sheet used as the primary haemostatic agent provided effective bleeding control, with no cases of post-tonsillectomy haemorrhage reported. The findings support ORC as a safe and effective option for achieving haemostasis following tonsillectomy.8

Overall, these studies demonstrate that nasal packing materials play an important role in achieving haemostasis and supporting postoperative recovery, with the selection of packing material may be guided by patient-specific consideration and surgeon preference.

Conclusion

Nasal packing helps support healing and recovery after septoplasty, inferior turbinoplasty, FESS and other nasal surgeries. Both absorbable and non-absorbable packs have their benefits depending on the patient’s needs and the type of procedure. Choosing the right nasal packing can help improve comfort, control bleeding, and support better recovery after surgery. With advances in nasal packing materials, postoperative care continues to become more comfortable and effective for patients.

FAQs

What is nasal packing used for?

Nasal packing is used to help control nose bleeding and support healing after nasal surgeries or injuries.

Which nasal packing is commonly used after ENT surgery?

Both absorbable and non-absorbable nasal packs are commonly used after ENT procedures depending on the surgical requirement and patient needs.

What is SURGI-PVA™ Nasal Pack used for?

SURGI-PVA™ Nasal Pack is used to help control bleeding and support recovery after nasal procedures such as septoplasty and sinus surgery.

Does nasal packing help prevent postoperative bleeding?

Yes, nasal packing helps apply gentle pressure inside the nose, which supports haemostasis and helps reduce postoperative bleeding.

Can nasal packing help after septoplasty or sinus surgery?

Yes, nasal packing is commonly used after these procedures to help control bleeding and support healing.

What are the other nasal packing products commercially available in the market?

In ophthalmic and microscopic surgeries, maintaining a clear surgical field is important for precision and visibility. Since eye tissues are highly delicate, even small amounts of excess fluid can affect surgical accuracy, making effective fluid management an essential part of the procedure.

While traditional cellulose-based sponges are commonly used, they may carry a risk of fibre shedding or residue during delicate procedures. PVA (polyvinyl alcohol) ophthalmic surgical sponges offer a cleaner and more controlled alternative for fluid management.

Designed for delicate ophthalmic procedures, microsurgical consumable spears such as SURGI-PVA™ Eye Spears help absorb excess fluid efficiently, allowing surgeons to maintain better visibility, focus and control throughout surgery.

What is SURGI-PVA™ Eye Spear?

SURGI-PVA™ Eye Spears are microsurgical consumable spears made using Air Foam Technology with PVA, a soft, highly absorbent, and retentive sponge material designed to absorb excess fluid from the operative field. Their pure, ultraclean, and residue-free structure makes them ideal for demanding LASIK and refractive surgeries.

Figure 1: SURGI-PVA™ Eye Spear  How It Works?

SURGI-PVA™ Eye Spears are designed with an ultraclean and lint-free structure, making them ideal for delicate ophthalmic procedures where clear visibility is important. Their soft open-cell structure of the sponge helps absorb and retain fluid effectively while expanding gently when moistened.

Key Functional Features:

Capillary-driven absorption: Microporous PVA structure quickly absorbs fluid upon contact

Uniform fluid retention: Interconnected pores distribute and securely retain fluid within the sponge

Controlled expansion: Expands gently to conform to the operative site without fibre release

Continuous fluid management: Helps minimize fluid re-migration and maintain a stable surgical field

Clear surgical visibility: Supports a clean and stable microsurgical field during procedures

Residue-free performance: Removes excess moisture and fine particles without leaving residue behind

Supports precision handling: Enables stable visualization and controlled tissue handling during delicate ophthalmic procedures

Why Choose PVA Eye Spears Over Cellulose Alternatives?

PVA Eye Spears are designed to provide clean, gentle, and reliable performance during delicate ophthalmic procedures. Unlike some cellulose-based spears that may shed fibres or cause tissue irritation, PVA sponge spears leave no microfragments on the scleral bed, helping maintain a cleaner surgical field and supporting safer tissue handling.1

These qualities make SURGI-PVA™ Eye Spears a dependable choice for maintaining clarity, control, and tissue safety during ophthalmic or microscopic surgeries.

Supporting Precision in Modern Eye Surgery

SURGI-PVA™ Eye Spears are designed for ophthalmic procedures that require precision, control, and delicate tissue handling, including LASIK, Femtosecond Lenticule Extraction (FLEx) and Small Incision Lenticule Extraction (SMILE), cataract surgery, and other ophthalmic microsurgeries.1,2

In advanced refractive procedures like FLEx and SMILE, maintaining a clear and stable surgical field is needed for accurate tissue handling and optimal outcomes.

In FLEx procedures, A PVA spear is used to gently absorb excess fluid from the flap edges, helping the flap remain securely positioned through surface tension.2

In SMILE procedures, the incision site is lightly patted with a slightly wet PVA spear after lenticule removal to manage residual moisture and support clean tissue handling.2

Their soft, highly absorbent, lint-free structure helps quickly manage moisture without leaving particles behind, supporting a clear operative field throughout the procedure.

Final Thoughts

In ophthalmic surgery, the right tools are essential for precision and patient care. SURGI-PVA™ Eye Spears are designed for delicate ophthalmic procedures, offering effective fluid management while protecting sensitive ocular tissues. Their ultraclean, lint-free structure helps maintain a clear surgical field without leaving residue behind, supporting surgical efficiency, accuracy, and reliable performance surgeons can trust.

FAQs

What material are SURGI-PVA™ Eye Spears made from? SURGI-PVA™ Eye Spears are made from polyvinyl alcohol (PVA), a soft, highly absorbent, and biocompatible sponge material. They are designed to efficiently manage fluids during ophthalmic and other microsurgical procedures.

Can SURGI-PVA™ Eye Spears be used in LASIK and refractive surgeries? Yes. They are suitable for LASIK, SMILE, FLEx, and other refractive and ophthalmic microsurgical procedures where precise fluid control is important.

How much fluid can a SURGI-PVA™ Eye Spear absorb? SURGI-PVA™ Eye Spears can absorb more than eight times their dry weight, helping manage fluid efficiently throughout surgery.

Do SURGI-PVA™ Eye Spears leave lint or residue behind? No. Their ultraclean, lint-free design helps keep the surgical field clean without leaving fibers or residue behind.

What technology is used to manufacture SURGI-PVA™ Eye Spears? They are manufactured using advanced Air Foam Technology, which provides consistent absorbency, fluid retention and reliable performance.

Endometriosis is a common, benign, estrogen-dependent condition affecting women of reproductive age. It often presents as ovarian endometriomas and may be associated with pelvic pain, dysmenorrhea, dyspareunia, infertility, or may be discovered incidentally during imaging or surgery.1,2

Surgical treatment options include fenestration with coagulation, laser vaporization, and laparoscopic cystectomy. Among these, cystectomy is generally considered the preferred approach, as it has been shown to reduce recurrence compared with drainage and ablation and is associated with better fertility outcomes.2,3 However, once the cyst is removed, achieving effective haemostasis from the ovarian bed can still be a challenging step in the procedure.

Why does the choice of haemostatic method matter in endometrioma surgery?

The method used to control bleeding during laparoscopic cystectomy for endometriosis can directly affect ovarian tissue. Choosing an approach that ensures effective haemostasis while minimizing tissue damage is essential to preserving ovarian function and long-term outcomes. After stripping the cyst wall, the subsequent bleeding of the ovarian stromal wound is usually controlled by bipolar coagulation or/and by suturing.4 The table below outlines the impact of different haemostatic methods on ovarian tissue.2–5

Table 1: Haemostatic Methods and Their Impact on Ovarian Tissue

To make this step more tissue-friendly, surgeons are increasingly using topical haemostatic agents such as gelatin-based matrices (e.g., FLOGEL®). These agents help achieve effective bleeding control by promoting natural clot formation while minimizing trauma to the surrounding ovarian tissue, making them a useful support in ovarian endometrioma surgery.

What is FLOGEL®?

FLOGEL® is a flowable gelatin-based haemostatic matrix supplied in a prefilled syringe for fast bleeding control, usually within 2–5 minutes. The flowable nature of FLOGEL allows it to conform to irregular wound surfaces and reach difficult-to-access areas.

It closely adapts to the bleeding site and can be combined with thrombin to enhance and accelerate the body’s natural clotting process. By providing effective haemostasis without thermal injury, it offers a practical and tissue-friendly alternative to electrosurgical methods.

What are the key features?

What does clinical evidence suggest?

A study of 20 patients undergoing laparoscopic endometrioma excision (cyst diameter 3–6 cm) compared haemostasis using a gelatin–thrombin matrix (n=8) with conventional haemostatic methods (bipolar forceps or CO₂ laser, n=12).

Key findings:3

Haemostasis was achieved in all cases within 3 minutes, with comparable outcomes to conventional methods (172 vs 182 seconds (about 6 minutes)) and no intra- or postoperative complications, bleeding, or transfusion requirements were reported.3

The study suggests that topical gelatin–thrombin matrix haemostatic agents may be a useful alternative to bipolar coagulation to reduce thermal damage to follicular or ovarian tissue and may help better preserve ovarian reserve after laparoscopic cystectomy for endometriosis.2,3

Conclusion:

A chronic subdural hematoma (cSDH) is a slow collection of blood and blood degradation products between the layers covering the brain.1,2 It often happens after a minor head injury, typically represents in adults. Over time, the pressure from this blood can affect the brain, leading to symptoms like headaches, confusion, or weakness. The image below shows where this type of bleeding can occur.1

What Makes cSDH Surgery Challenging?

cSDH is primarily treated with surgical evacuation using techniques such as burr holes, craniostomy, or mini craniotomy with or without membranotomy and standard hemicraniectomy. However, symptomatic recurrence remains a major challenge. Persistent micro bleeding drives this issue, leading to the following concerns:2–5

Recurrence due to fragile neomembrane bleeding

Higher risk in multilayered cSDH (laminar, separated, gradation types)

Patients often trapped in a cycle of repeated surgery

Patient-related factors such as tissue fragility, high surgical risk, and anticoagulant use, increasing bleeding complications

This highlights the need for an adjunctive solution that not only controls bleeding but also supports long-term stability. In such cases, products like oxidized regenerated cellulose (Surgi-ORC®) can play a role in managing multilayered cSDH. Therefore, Let’s explore Surgi-ORC® and how this technique is applied in treatment.

How Does Surgi-ORC® Work?

Surgi-ORC® is a natural, plant based absorbable haemostat made up of oxidized regenerated cellulose, designed to stop capillary, venous and minor arterial bleeding. The fibrillar form is used during such surgery to enhance surface contact and promote effective haemostasis.

ORC Supporting Surgical Precision:

Incorporating ORC into advanced techniques, such as membrane tucking with intermembranous placement, provides a targeted approach to address the source of bleeding. This method helps stabilize the subdural space and may reduce the likelihood of recurrence.2

What Does a Clinical Experience Show?

Emerging evidence supports the use of ORC as an adjunct in cSDH surgery. In a study of 23 patients with multilayered cSDH confirmed on preoperative MRI, the novel surgical technique was applied. The cohort had a mean age of 61.34 years, a male-to-female ratio of 4.75:1, and included laminar (26.08%), separated (56.52%), and gradation (17.39%) type cSDH. Stepwise surgical technique for multilayered cSDH:2

Key observations:2

• 0% postoperative recurrence, assessed at day 1 and 3-month follow-up scans • 0% reoperation rate in this series • 0% ORC-related complications, with no adverse events from ORC or Ligaclips

The technique combining membrane tucking with ORC Fibrillar placement was found to be safe, effective, and reproducible, with potential to reduce recurrence.²

Conclusion

From Hemostasis to Healing: SURGISPON® in Gynecological Procedures

Gynecological surgery includes a wide range of procedures involving the female reproductive system. These include treatment of uterine fibroids, endometriosis, ovarian cysts, abnormal uterine bleeding, gynecological cancers, pelvic inflammatory disease, ectopic pregnancy, and fertility-related interventions.1 While these surgeries are frequently performed, they come with potential complications like infections, bleeding, damage to organs and scarring.1,2 Bleeding is a common challenge in pelvic surgery because these organs have a rich blood supply. If not controlled, it can make it harder to see clearly and may increase the risk of complications.

To meet this challenge, a range of haemostatic agents have been developed. Among them, gelatin sponge-based agents such as SURGISPON® absorbable haemostatic sponge are widely used due to their ease of use, biocompatibility and effectiveness in achieving haemostasis, thereby contributing to improved surgical outcomes.

To better understand its clinical utility, it is important to examine the composition, mechanism of action, and applications of SURGISPON®.

What is SURGISPON®?

SURGISPON® absorbable haemostatic sponge is a fast-acting haemostat that rapidly controls bleeding and absorbs up to 45 times its weight in blood and fluids.

It is versatile for intraoperative use, including tamponade and shaping for complex gynaecological sites, and can also serve as a carrier for localized drug delivery. It is available in sponge, anal tampon and powder forms, with multiple density and thickness options.

Now let us get into what really defines SURGISPON® — its key characteristics, the benefits it brings, and where it is indicated.

What are the key characteristics of SURGISPON®?

What are the key benefits?

Where is SURGISPON® used in gynaecology?

What Does the Evidence Show?

Available studies support its role in gynaecological practice.

A pilot study involving 15 patients undergoing myomectomy for fibroids evaluated the use of diluted vasopressin and a gelatin absorbable sponge for hemostasis. After myoma removal, the sponge was applied to the myoma bed before closure, resulting in effective bleeding control. Most cases showed low intraoperative blood loss, with operative times ranging from 60–150 minutes and postoperative hemoglobin remained unchanged in three cases.2

In a randomized study of 164 patients undergoing elective caesarean section, a bupivacaine-soaked gelatin sponge significantly reduced postoperative pain compared to control group. Fewer patients required rescue analgesia, with lower opioid and diclofenac use.3

These findings suggest that the use of a bupivacaine-soaked gelatin sponge may be an effective technique in obstetric and gynecological procedures to reduce anxiety level and postpartum depression rate postoperative pain and enhance recovery.3,4 However, it should be noted that SURGISPON® is not indicated for the control of postpartum hemorrhage or menorrhagia.

Conclusion:

Cardiac surgery is a type of surgery performed on the heart and its associated blood vessels, involving delicate, highly vascular structures that require precise surgical care.1 Despite continuous advancements in surgical techniques, achieving effective haemostasis remains a critical challenge.2

Bleeding particularly diffuse oozing from soft tissues, sternal bone marrow, and surgical sites can increase the risk of complications. This challenge is even more pronounced in patients with comorbidities or those receiving antiplatelet therapy.2 Therefore, effective bleeding control is essential for safe outcomes.

Why is effective haemostasis so important in cardiac surgery?

Inadequate control of bleeding during cardiac surgery can lead to several complications, including:3,4

Increased blood loss

Higher transfusion needs

Longer surgery and ICU stay

Risk of reoperation due to excessive bleeding

Complications such as tamponade or wound infection

Impaired wound healing, seromas and sternal dehiscence

Complications during the healing process in the sternotomy like severe osteomyelitis, purulent pericarditis and mediastinitis

Challenges with conventional haemostatic techniques:

Given these risks, surgeons rely heavily on conventional haemostatic methods — but are they always enough?

While electrocautery and bone wax are widely used for bleeding control, they may not be sufficient in all situations, particularly in cases of diffuse sternal intramedullary bleeding. Electrocautery is effective for controlling bleeding in soft and adipose tissues; consequently, it is ineffective for bone. Bone wax is commonly used to control sternal marrow bleeding due to its effectiveness and low cost; however, it can impair bone healing by inhibiting osseous fusion and may increase the risk of infection.2,3 These limitations highlight the need for advanced haemostatic solutions that can provide effective control without compromising healing.

In such cases, oxidized regenerated cellulose (ORC) such as Surgi-ORC®,offers a practical and reliable option. It can be easy to apply over the sternotomy site, particularly along the intramedullary surface, helping to control bleeding before closure. This is where Surgi-ORC® can truly make a difference.

What is Surgi-ORC®?

Before exploring its clinical advantages, let’s understand what makes Surgi-ORC® unique. Surgi-ORC® is a plant-based absorbable haemostat made up of oxidized regenerated cellulose (ORC) designed to stop capillary, venous and minor arterial bleeding. It is available in multiple forms, including Non-woven, Fibril, Knit, Original/Standard and Powder.

This flexibility allows surgeons to choose the most appropriate form for the situation. But what makes it particularly effective in cardiac surgery?

Why Surgi-ORC® cardiac surgery?

All these features make it a useful and effective adjunct in routine cardiac surgery.

What are the application areas of Surgi-ORC®?

With its wide range of applications, Surgi-ORC® helps surgeons achieve reliable bleeding control across different and complex cardiac procedures.

Clinical Evidence

Clinical data support the use of ORC in cardiac surgery. A retrospective study in CABG patients (September 2022–March 2023) compared outcomes with and without the use of standard absorbable ORC haemostat.

Patients treated with ORC standard demonstrated:4

Reduced operative time

Lower transfusion requirements

Faster ICU recovery

Earlier chest tube removal

Importantly, these findings were statistically significant (p < 0.05), suggesting a positive role for ORC in supporting effective bleeding control.4

Conclusion

World Health Expo Miami (FIME) isn’t just an event; it’s where healthcare ideas come to life and shape the future. By bringing together healthcare innovators, exhibitors, industry leaders, buyers, and investors, it creates meaningful connections and drives real progress.

From discovering new trends to building partnerships and exploring transformative solutions, WHX Miami helps turn ideas into impact.

Spot emerging trends in the healthcare industry

Connect with decision-makers

Build global partnerships

Drive business growth

Aegis at WHX Miami: A Continuing Journey

Last year, Aegis Lifesciences participated in WHX Miami (formerly FIME), creating an engaging booth experience through product showcases, live demonstrations, and meaningful interactions with healthcare professionals from across the globe.

The images below capture moments from our previous participation, highlighting the valuable connections and experiences shared during the event.

WHX Miami continues to be an important platform for connecting with the global healthcare community and showcasing our commitment to advancing surgical care and improving patient outcomes.

Aegis Lifesciences at WHX Miami 2026

Continuing this journey, Aegis Lifesciences is proud to participate in WHX Miami 2026, taking place from June 17–19, 2026, at the Miami Beach Convention Center (Booth C29).

Aegis Lifesciences is proud to be part of this dynamic event, presenting a broad portfolio of haemostatic solutions for effective surgical care. Through our trusted solutions, we aim to support safer surgeries and better patient outcomes.

Showcasing Our Advanced Haemostatic Solutions

At WHX Miami 2026, we are proud to showcase a broad range of haemostatic solutions for both human and veterinary care, designed to support safer and more reliable surgical procedures.

Our featured solutions include:

SURGISPON®– Absorbable gelatin sponge and powder designed to support quick and effective haemostasis

DENTOSPON®– Foam gelatin with colloidal silver, designed to support haemostasis and help protect against oral microorganisms

FLOGEL®– Flowable gelatin haemostatic matrix for managing bleeding in tight, irregular, and difficult-to-reach surgical sites

HAEMOVET®– Absorbable haemostatic solutions developed to provide quick and effective haemostasis during veterinary surgeries and dental procedures

Surgi-ORC®– Natural, plant-based absorbable haemostat made from oxidized regenerated cellulose, designed to control capillary, venous, and minor arterial bleeding

SURGI-PVA™– Polyvinyl alcohol medical sponges and dressings designed for effective fluid control, including nasal packs and eye spears

Figure 1: Comprehensive Range of Haemostatic Solutions

Our participation at FIME reflects Aegis Lifesciences’ focus on advance, quality manufacturing, patient-centered care, and building strong global healthcare collaborations.

Why Should Global Distributors Visit Aegis Lifesciences at FIME?

Aegis Lifesciences is trusted by healthcare buyers and distributors worldwide for its focus on quality manufacturing, reliable supply, and long-term partnerships. At FIME, visitors can explore our broad portfolio of haemostatic solutions designed to support the evolving needs of modern surgical care.

Key advantages include:

Global supply capability

Gamma sterilized with SAL 10⁻⁶ assurance

Cost-effective haemostatic solutions with up to 30% lower costs compared to the global average

Continuous investing in R&D for innovative haemostatic product

FDA-registered and ISO 13485-certified manufacturing facility

Certifications from BSI Netherlands and DNV Norway

MDSAP compliance for Australia, USA, Japan, Brazil, and Canada

Facility certified by Globally recognized audit and MOH of various countries

Product registrations in 80+ countries

Our team works closely with partners to provide tailored haemostatic solutions for diverse healthcare markets across the globe.

Looking Ahead to WHX Miami 2026

As healthcare continues to evolve, platforms like WHX Miami create valuable opportunities for collaboration, innovation, and knowledge sharing.

We look forward to welcoming visitors, partners, and industry professionals as we showcase our range of haemostatic solutions and connect through meaningful discussions around the future of surgical care.

At Aegis Lifesciences, we remain committed to supporting safer surgeries and better outcomes through trusted and effective solutions.

The Role of FLOGEL® in Pituitary Tumor Surgery

Pituitary tumor surgery, often performed via a minimally invasive transsphenoidal approach, allows direct gland access and faster recovery. However, the complex anatomy of the sellar region and its closeness to vital structures require high precision.1–3

Furthermore, oozing from the surgical wall cavities from the dural or nervous tissue may be troublesome and raise complications risk, making effective hemostasis crucial.4 While bipolar cautery controls bleeding but risks damaging healthy neural tissue, with deleterious neurological sequelae.4 Therefore, flowable gelatin-based hemostatic agents are useful in this setting as they enable precise bleeding control and support safer pituitary and skull base surgery.

Figure 1: Endoscopic Transsphenoidal Approach for Pituitary Tumor Surgery1 Why hemostasis matters in pituitary neurosurgery

Effective bleeding control in transsphenoidal surgery is essential to ensure optimal surgical outcomes. 1,2 Inadequate hemostasis may result in:

Bleeding obscures visualization, making surgery less safe

Increases risk of intraoperative complications and neurovascular injury

Poor control can lead to postoperative hematoma, a common cause of reoperation and morbidity

Antiplatelet and anticoagulant use adds surgical challenges

Raises the need for blood transfusion, which carries risks such as infection, coagulopathy, and fluid overload

In such scenarios, flowable hemostatic matrices like FLOGEL® provide an effective solution for rapid and controlled hemostasis. But what makes this approach particularly suitable for such complex procedures? Let’s take a closer look.

What is FLOGEL®?

FLOGEL® is a flowable gelatin hemostatic matrix made from absorbable sponge powder, prefilled in a 20 mL syringe. Supplied as a complete sterile, gamma-irradiated kit with all necessary accessories.

Figure 2:FLOGEL® Flowable Gelatin Haemostatic Matrix This FLOGEL® design ensures both precise and easy to use during surgery.

Why FLOGEL®?

These features make FLOGEL® effective for quick bleeding control. To better understand its real-world impact, let’s explore the clinical evidence supporting its use.

Clinical experience with pituitary tumor surgery

A consecutive series of 318 patients (mean age 58.8 years) under elective and emergency cranial, craniospinal, and spinal surgeries (January 2005 and March 2012). The most common intracranial tumors treated were glioma, meningiomas, and pituitary tumors. All patients received a gelatin hemostatic matrix, achieving immediate hemostasis with no intraoperative hemorrhage in the operative cavity and no agent-related complications.4

Figure 3: a. Intraoperative picture of endoscopic removal of pituitary tumor from internal carotid artery during a trans-sphenoidal approach. b. Endoscopic view of gelatine hemostatic matrix after removal of the pituitary tumor4 This study suggests these adjuncts to hemostasis are of great value for neurosurgeons in cases of difficult hemostasis.4

Conclusion

The nasal turbinates help control airflow inside the nose and support normal breathing. A common problem in ENT practice is nasal blockage caused by inferior turbinate hypertrophy, which can happen due to conditions like rhinitis or deviated nasal septum. This may lead to long-term nasal obstruction, discomfort, and sleep problems.1

When medicines do not provide enough relief, surgeons may perform partial inferior turbinectomy (PIT) to improve airflow. However, after this surgery, doctors often need to manage issues such as bleeding, pain, slow healing, and intranasal adhesions (synichae).1,2

To help reduce these problems, surgeons use haemostatic agents and nasal packing materials. Two commonly used options are Oxidized Regenerated Cellulose (ORC), such as Surgi-ORC® and Polyvinyl Alcohol (PVA) nasal packs like SURGI-PVA™. Together, these solutions help control bleeding, support healing, and improve recovery after turbinate surgery.

What is Surgi-ORC® ?

What is SURGI-PVA™ ?

Why to use SURGI-PVA™ ?

Clinical evidence:

In a prospective, randomized study of 120 patients undergoing bilateral partial inferior turbinectomy (PIT), patients were allocated into two groups (n=60 each) using block randomization (block size 4). Group A received intranasal ORC sheet (Surgicel®), while Group B underwent surgery without ORC. Initial hemostasis in both groups was achieved using ribbon gauze soaked in Xylocaine and Xylometazoline.

In Group A, two layers of ORC were placed over the bleeding area on the medial wall of the inferior turbinate. Postoperatively, anterior PVA nasal packs (8 or 10 cm long) were left in situ for 2 days and the intranasal ORC were sucked out after 48 hours.1

Key Findings:

Table 1: Comparison between the 2 groups at 48 hours postoperatively1

Data presented n (%); *no statistically significant difference

This study found that intranasal Surgicel® after PIT can help reduce pain and bleeding, speed up haemostasis and lower the risk of postoperative adhesions.1

Conclusion

Neurosurgery demands precision not just during the operation but also throughout the healing process, which plays a critical role in overall surgical outcomes. In repeat procedures especially for recurrent gliomas surgeons often encounter meningo-cerebral adhesions. Managing these adhesions can prolong surgery and increase the risk of focal cortical injury. They usually develop due to inflammation and disruption of the fragile dural border cell layer during surgery, which may ultimately affect patient survival and quality of life. 1–3

For this reason, preventing adhesion during the first surgery is crucial. Careful technique and good haemostasis support healing, repair the dural defect and reduce adhesion risk, showing the value of supportive surgical adjuncts.1,3

Why is prevention of meningo-cerebral adhesions important?

Meningo-cerebral adhesions are commonly seen during repeat surgeries for high-grade gliomas. When these adhesions must be separated, they can lead to several intraoperative challenges:2,3

Difficult and potentially risky re-entry during repeat surgery

Longer operative time

Challenging dural opening with pia-arachnoid disruption and cortical bleeding

Therefore, in patients who may require future neurosurgical procedures, preventing adhesion formation becomes particularly important.

A safe and effective method for preventing meningocerebral adhesions:

One effective approach is to create a barrier between the injured leptomeninges and the dura during the healing phase. A haemostatic gelatin sponge, such as SURGISPON, can serve this purpose effectively. While other collagen-based materials may offer similar benefits, gelatin sponges stand out for their ease of handling, wide availability, and cost-effectiveness.3

Let’s know about SURGISPON®

What isSURGISPON®?

SURGISPON® is a gamma-sterilized, non-toxic, absorbable gelatin sponge designed to provide fast and effective bleeding control and support neurosurgical procedures. It is available in sponge, powder, and particle forms, in both normal and high-density compressed variants, and in multiple thicknesses (10 mm, 5 mm, 2 mm, 1 mm and 0.5 mm) and 1 g and 3 g powder options.

Figure 1: SURGISPON® Absorbable Haemostatic Gelatin Sponge

What makes SURGISPON®valuable in this setting?

SURGISPON® is designed to control arterial, venous, and diffuse bleeding, particularly when conventional methods are insufficient.

Together, these features make SURGISPON® a practical adjunct for effective bleeding control and improved surgical outcomes.

How does SURGISPON® help surgeons manage such adhesion challenges?

Importantly, research shows that gelatin sponges can help reduce postoperative pain and opioid use, support haemostasis, and assist in dural repair when combined with controlled fibrin glue application.1,4 In addition, placing a thin gelatin sponge during dural closure can create a protective barrier between the dura and brain, promoting better healing.3

How does gelatin spongehelp surgeons manage adhesion challenges?

Preventing meningocerebral adhesions mainly involves creating a barrier between the disrupted leptomeninges and the dura during healing. Gelatin sponges support this by acting as a biocompatible, nearly inert barrier made of partially fragmented connective-tissue polypeptides.³

So, what does clinical evidence say about this approach? Let’s take a closer look.

Clinical evidence:

Figure 2. (A) Exposed cortex after haemostasis during right pterional craniotomy. (B) Thin gelatin sponge placed over the cortex to separate the dura and protect it during closure.3

Figure 3. (A) Intraoperative view via right pterional craniotomy of group G. Membrane free of attachments in the anterior two-thirds of the Sylvian fissure; asterisk marks area covered by gelatin sponge in the first surgery. Uncovered areas adhered to dura. (B) Membrane stripped with no attachments; temporal operculum visible.3

This study proves that, during the dural closure, placing a thin layer of gelatin sponge in the subdural space is a safe and effective method for preventing meningocerebral adhesions.3

Conclusion

In neurosurgical operations, posterior fossa tumor removal is a very delicate procedure because it is operating near vital structures such as the cerebellum and brainstem within confined space.1 Posterior fossa tumours are more common in children than adults, accounting for 54–70% of paediatric brain tumours compared with 15–20% in adults and occur more frequently in males.2–3

Continuous bleeding can obscure the surgical field, making it difficult for the surgeon to identify and control the source of bleeding. This not only complicates the procedure but also increases the risk of injury to surrounding tissues and serious complications, including brainstem compression, herniation and mortality.3 Hence, prompt and effective haemostasis is essential for maintaining bleeding control and a clear surgical field.

What complications can occur in a postoperative posterior fossa patient?

Posterior fossa surgery carries a high risk of complications, primarily due to the anatomical proximity to the brainstem and lower cranial nerves. These complications include:

Neurological / Surgical Uncontrolled intraoperative bleeding may lead to poor visibility, neural injury, prolonged surgery, increased transfusion needs, hematoma formation, wound infection and other complications such as edema, hydrocephalus, cerebellar mutism, cranial nerve impairment, and CSF leak.2–5,7

Airway / Respiratory Loss of protective airway reflexes, dysphagia, failed extubation, respiratory failure, need for tracheostomy.2,5,

Cardiopulmonary / Systemic Postoperative sepsis/septic shock/systemic inflammatory response syndrome, pulmonary complications, hospital stay increased.2,6

Because the posterior fossa is a small and highly sensitive space, even minor perioperative bleeding can have serious consequences, potentially increasing morbidity and mortality.3,4 Therefore, effective haemostatic solutions such as FLOGEL® are essential for safer surgery and improved patient recovery. Let’s understand FLOGEL® and how it helps in the operating room.

What is FLOGEL®?

FLOGEL® is a flowable gelatin haemostatic matrix, composed of absorbable gelatin sponge (USP) powder, prefilled in a syringe. It appears off-white to slightly yellow and is supplied prefilled in a 20 mL syringe. The syringe and all preparation accessories are provided together as a sterile, gamma-irradiated kit.

Figure 1: FLOGEL® Flowable Gelatin Haemostatic Matrix

This formulation enables precise delivery and ease of use in the surgical setting.

Why FLOGEL®?

FLOGEL® is a flowable gelatin haemostatic matrix, works through platelet adhesion, accelerating platelet plug formation to aid in fibrin clot formation. It is designed for easy application to a bleeding site that occurs in tight and irregular spaces, especially at a difficult to reach surgical site.

Together, these features make FLOGEL® an effective and faster bleeding control. Let’s now look at the clinical evidence supporting its effectiveness of flowable gelatin haemostatic matrix in such a procedure.

Clinical experience in pediatric patients undergoing posterior fossa surgery

Retrospectively analyzed (Between Jan-2012 and Dec-2016), 23 children (12 patients were female and 11 male) underwent posterior cerebral fossa surgery for low-grade gliomas. Standard haemostasis was achieved, followed using a thrombin-gelatin haemostatic matrix to strengthen haemostasis. Postoperative MRI and clinical follow-up revealed no matrix-related or delayed complications, supporting its safety and utility in pediatric posterior fossa surgery.5

Figure 2. a) Preoperative MRI showing a lesion within the fourth ventricle b) Postoperative T1-weighted MRI confirming gross total resection without haemorrhage; histology: ependymoma (WHO grade II) c) Tumor exposure below the cerebellar haemispheres d) Surgical field filled with thrombin-gelatin haemostatic matrix5

In this study, the thrombin-gelatin haemostatic matrix sealant was found to be a valid and safe tool for strengthening haemostasis in pediatric low-grade posterior fossa surgery.5

Conclusion

Introduction

Minor oral surgery, a focused subspecialty of oral and maxillofacial surgery, encompasses procedures involving the teeth, gingiva, alveolar bone, and adjacent soft tissues.¹ These procedures such as tooth extractions, periodontal interventions, biopsies, and alveoloplasty are routinely performed to relieve pain, restore oral function, facilitate prosthetic rehabilitation, and aid in the diagnosis or management of infections and tumors.¹˒²

While minor oral surgical procedures are generally considered safe, postoperative bleeding remains one of the most frequent complications and is significantly increased in patients with liver cirrhosis due to impaired coagulation.

In such high-risk populations, achieving rapid and reliable local hemostasis is essential. Alongside systemic optimization, topical hemostatic agents play a critical role in minimizing postoperative bleeding and reducing procedure-related morbidity.

What challenges do surgeons face when performing oral surgery in patients with cirrhosis?

Oral surgery in patients with cirrhosis is challenging due to impaired coagulation (involves reduced clotting factors, thrombocytopenia, platelet dysfunction, and altered fibrinolysis), increased bleeding risk, susceptibility to infection and altered drug metabolism.2–5 Even minor procedures can lead to significant blood loss and complications. Therefore, rapid and effective hemostasis is critical, and oxidized regenerated cellulose (ORC)–based topical agents, such as Surgi-ORC®, provide reliable local bleeding control in these high-risk patients.

Next, let’s explore Surgi-ORC® in more detail and understand how it can support effective bleeding control in these patients.

What is Surgi-ORC®

Surgi-ORC® is a plant-based, absorbable hemostat made from oxidized regenerated cellulose. It does not interfere with healing and is commonly used in general surgery, post-extraction alveolitis (dry socket) and periodontal procedures. Surgi-ORC® is available in ORIGINAL/STANDARD, KNIT, FIBRIL and NON-WOVEN/SNOW forms.

How does Surgi-ORC® work at the bleeding site for such patients?

Managing bleeding in patients with cirrhosis can be challenging, and conventional methods like ligation are often ineffective or impractical. Surgi-ORC® offers a reliable solution by controlling bleeding through a physical effect without interfering with the body’s natural clotting process.

These combined actions make Surgi-ORC®a reliable choice for controlling bleeding during minor oral procedures, with practical features that support safe and effective clinical use.

How Does Surgi-ORC® Achieve Hemostasis?

Surgi-ORC® is an absorbable topical hemostatic developed for rapid, localized control of bleeding from capillary, venous, and small arteriolar vessels. Its mechanism of action involves:

Absorbs blood and swell into brownish-black gelatinous mass, providing a protective barrier over the injury site

Creation of a localized low-pH environment that promotes vasoconstriction

Functioning as a matrix for platelet adhesion, thereby facilitating clot formation

What features make Surgi-ORC® clinically useful?

Surgi-ORC® offers several features that make it clinically useful, including:

Together, these features make Surgi-ORC® a safe, effective, and user-friendly option for managing bleeding in such patients.

What does clinical evidence suggest about its effectiveness?

A prospective, randomized, single-blind study of 50 patients with cirrhosis undergoing minor oral surgery (40 teeth per group) reported comparable hemostatic efficacy for Surgicel® (oxidized regenerated cellulose) and Celox™ (chitosan-based agent), with mean hemostasis times of 2.94 and 3.38 minutes, respectively (p > 0.05). No platelet transfusions or material-related complications were observed, results indicating that both ORC and chitosan-based agent are safe and effective for bleeding control in such patients.4

Conclusion

Laparoscopic cholecystectomy (LC) is a minimally invasive procedure for gallbladder removal in gallstone disease (cholelithiasis) and related complications. Compared with open surgery, LC offers less postoperative pain, shorter hospital stays, faster recovery, and better cosmetic outcomes.1,2

What clinical conditions commonly require LC?

LC is indicated in a wide range of gallbladder conditions, including3

Cholelithiasis

Mucocele or empyema of the gallbladder

Cholesterolosis

Typhoid carrier

Porcelain gallbladder

Acute cholecystitis (calculous and acalculous)

Adenomatous gallbladder polyps

As part of other procedures, viz., whipple’s procedure

Although LC generally provide better outcomes across these indications, effective haemostasis remains essential for procedural safety, as bleeding continues to be the most serious non-biliary complication.4

Why bleeding control is critical during LC?

If not promptly managed, bleeding is a leading cause of procedure-related mortality. 4While electrocautery is the conventional tool for bleeding control, its thermal nature carries risks (damage to parenchymal tissue and postoperative bile leakage);1 hence, topical oxidized regenerated cellulose (ORC) agents such as Surgi-ORC®, can be used to achieve haemostasis and reduce these complications.

What is Surgi-ORC®?

Surgi-ORC® is a plant-based, absorbable haemostatic made of oxidized regenerated cellulose designed to control bleeding. ORC adheres easily to bleeding surfaces and is suitable for use in laparoscopic cholecystectomy.1 Surgi-ORC® is available in four variants: Surgi-ORC® ORIGINAL, Surgi-ORC® FIBRIL, Surgi-ORC® NON-WOVEN and Surgi-ORC® KNIT, haemostats.

How Does Surgi-ORC® Work to stop bleeding?

Surgi-ORC® is an absorbable topical haemostatic designed for rapid, localized control of bleeding from capillary, venous, and small arteriolar vessels. It works by:

ORC absorbs blood and forms a gel that covers the site of vessel injury

Creates a low-pH environment, leading to localized vasoconstriction

Acts as a matrix for platelet adhesion, accelerating clot formation

What advantages does Surgi-ORC® offer in LC?

Together, these benefits make Surgi-ORC® particularly valuable in complex and high-risk cases.

Clinical Evidence: Efficacy of ORC in LC

A study conducted between January 2012 and August 2015 included 525 patients with acute cholecystitis undergoing fundus-first LC. Patients were classified by dissection difficulty: Group A (n=142) had an easily achieved Critical View of Safety (CVS), while Group B (n=383) had a difficult field with higher complication risk.5

Key Findings:5

Haemostasis was achieved, the liver bed packed with surgical fibrillar absorbable haemostat (ORC), and a drain placed when necessary.

No postoperative bile leaks, re-explorations, re-hospitalization, biliary system procedure (MRCP/ERCP), or conversions to open surgery were reported

Even in technically difficult cases, safe haemostasis was achieved

These findings demonstrate that ORC significantly contributes to bleeding control and reduces surgical risk.

Conclusion

Laparoscopic nephrectomy is a minimally invasive surgical procedure for kidney removal, performed through small incisions using a specialized tool (laparoscope). This approach reduces postoperative pain, hospital stay, recovery time and convalescence compared with open procedure.1,2

When is laparoscopic nephrectomy recommended?

Laparoscopic nephrectomy is recommended for the treatment of most benign kidney diseases in which there is permanent loss of renal function. Common indications include1:

Chronic pyelonephritis

Obstructive or reflux nephropathy

Renal tuberculosis and Nephrosclerosis

Multicystic dysplastic kidney

Renovascular hypertension and post-transplant hypertension

Acquired renal cystic disease in dialysis patients

Symptomatic patients with autosomal dominant polycystic kidney disease

With advances in laparoscopic technology and years of clinical experience, laparoscopic nephrectomy is now considered a clear winner over open nephrectomy surgery.1 However, controlling surgical bleeding remains one of the most critical challenges.

Since nasal packing plays such an important role, let’s take a closer look at the material used and how it supports safe and comfortable healing.

Why haemostasis matters in laparoscopic nephrectomy

The kidney’s high vascularity makes bleeding control critical during laparoscopic nephrectomy. Inadequate haemostasis can lead to:1,2

Excessive parenchymal bleeding that obstructs renorrhaphy

Minor bleeding can obscure the field and prolong surgery

Increased overall surgical risk and compromise procedural success

Therefore, effective haemostasis is essential for procedural safety and optimal recovery. Haemostatic agents such as SURGISPON®, Surgi-ORC® and FLOGEL® are designed to meet this need, offering rapid and effective bleeding control.

Let’s explore these products, their benefits, and how they help make laparoscopic nephrectomy safer and more effective.

A. SURGISPON®: Absorbable Haemostatic Sponges

SURGISPON® is a gamma-sterilized, non-toxic, non-immunogenic absorbable gelatin sponge designed for rapid and effective haemostasis. Its uniform porosity and unique interconnected structure provide high absorption capacity up to 45 times its weight. It is easy to trim and can be used either dry or pre-saturated saline water.

B. Surgi-ORC®: Advanced Plant-Based Haemostatic Solution

Surgi-ORC® is a sterile, absorbable haemostatic product made from oxidized regenerated cellulose (polyoxy-anhydro-glucuronic acid). It is free from animal- and collagen-derived additives, supports suturing and can be sutured and can be cut without fraying.

C. FLOGEL®: Flowable Gelatin Haemostatic Matrix

FLOGEL® is a flowable absorbable gelatin sponge powder prefilled in a syringe. It is designed for easy application to bleeding sites in tight or irregular spaces, especially at difficult to reach surgical areas.

Clinical Evidence

A retrospective analysis of 126 patients undergoing laparoscopic partial nephrectomy evaluated three haemostatic agents: Spongostan™ (absorbable gelatin sponge), Surgicel® Original (oxidized regenerated cellulose) and Floseal® (haemostatic matrix).3

Key findings3:

Operative time, warm ischemia time, complication rates and length of hospital stay were similar across groups; however, haemostatic matrix significantly reduced blood loss (p = 0.01).

Overall, the choice of haemostatic agent affected blood loss but did not impact other surgical outcomes or early renal function.

Conclusion

Nasal septoplasty is a common ENT and plastic surgery procedure performed to correct a deviated septum and improve nasal breathing. Postoperative care is essential to arrest hemorrhage, reduce pain and prevent complications. Conventional nasal packing methods often cause discomfort, pain and bleeding particularly during removal.1 To address this, absorbable materials such as SURGISPON® gelatin sponge provide a gentler alternative. To better understand how recovery can be improved, let us first explore why nasal packing is important after septoplasty.

Why is nasal packing important after septoplasty?

Nasal packing plays a key role in supporting healing and preventing postoperative complications.2,3

Since nasal packing plays such an important role, let’s take a closer look at the material used and how it supports safe and comfortable healing.

What is SURGISPON® ENT?

SURGISPON® ENT is an absorbable haemostatic gelatin sponge designed for ENT surgeries to control bleeding and to support vital tissue structures, enhancing patient comfort. It is available in multiple forms including Standard, Cube, Sheet, Strip, and Tampon.

With a better understanding of what SURGISPON® is, let’s look at the practical benefits it offers for both patients and surgeons.

What are the key benefits of using SURGISPON® gelatin sponge for nasal packing?

SURGISPON® ENT provides efficient bleeding control while promoting comfortable and smooth healing.

These benefits make recovery smoother and safer for patients, with clinical studies supporting the use of gelatin sponge in this surgery.

Clinical Evidence A multicenter, randomized study with 76 septoplasty patients compared gelatin sponge and polyvinyl acetate packs in the same patients.3

The findings are summarized below: Gelatin sponge and Polyvinyl acetate packs3

Patient Comfort: Gelatin sponge caused less nasal obstruction and discomfort (p < 0.001)

Pain on Removal: Significantly lower with gelatin sponge (p < 0.001)

Haemostasis after removal: Gelatin sponge achieved significantly faster haemostasis after removal compared with polyvinyl acetate packs (p<0.001)

Degree of bleeding on removal: Bleeding after pack removal was significantly lower in Gelatin sponge than Polyvinyl acetate pack (p < 0.001)

Cost of pack: Gelatin sponge is comparable in cost to polyvinyl acetate packs, making it a cost-effective alternative.

Conclusion

Third molar surgery (wisdom tooth extraction) is a common dental procedure to remove impacted or problematic third molars.

Reasons for extraction:1–2

Impaction: Lack of space can prevent proper eruption, causing pain, infection, or damage to nearby teeth.

Infection and Disease: Conditions like pericoronitis or dental caries may require removal.

Preventive Measures: Sometimes extracted prophylactically to avoid future complications, especially in younger patients.

What is Surgi-ORC®?

Surgi-ORC® is a natural, plant-based absorbable haemostat made from oxidized regenerated cellulose (ORC). It is designed to fix the shortcomings of traditional ORC materials and is biocompatible, fast-acting, bactericidal, easily cut, flexible, suturable, and usable dry around bleeding sites.

What complications can occur after third molar extraction?

Complications range from mild pain and swelling to serious conditions such as nerve injury, mandibular fracture and life-threatening infections, as shown below.1–4

Some complications are minor, while others may require additional treatment to ensure a smooth recovery. Keeping bleeding under control and helping the healing process are key to improving patients’ comfort and recovery. In this context, SURGISPON® Dental is specifically designed to meet the needs of dental and oral surgeries.

What is a SURGISPON® DENTAL?

This is gamma-sterilized, absorbable gelatin sponge designed for rapid haemostasis in dental procedures. It can absorb up to 45 times their weight in blood and be fully absorbed within 4 weeks.

SURGISPON® Dental provides effective bleeding control and can be safely used with antibiotics or chemotherapeutics.

What are the key features?

What are the benefits?

What does clinical evidence say?

The clinical study evaluated 30 patients underwent bilateral mandibular wisdom tooth extraction using a split-mouth design6

Study group: Hyaluronic acid (HA) solution applied with SURGISPON® (gelatin sponge) as a scaffold

Control group: SURGISPON® alone placed intra-socket

Key clinical outcomes6

When comparing HA with SURGISPON® versus SURGISPON® alone, this study demonstrated:

1. Facial Swelling: Significantly reduced on postoperative days 2 and 7 in the study group; SURGISPON® alone still supported predictable healing 2. Trismus (Mouth Opening): Both groups showed postoperative mouth-opening limitation, with significantly better recovery in the study group on days 2 and 7 3. Pain and Analgesic Consumption: Lower pain scores in the study group during days 1–3 (p = 0.001); the control group required more analgesics yet healed without complications

Conclusion

The ear, nose and throat (ENT) area is delicate and richly supplied with blood vessels and nerves, making even minor surgeries prone to bleeding and complications. Procedures such as posterior turbinectomy, medial maxillectomy, nasal neurotomy, gland excisions, adenoidectomy, tonsillectomy, and endoscopic sinus surgery carry particularly high bleeding risks.1–4

Traditional hemostatic methods, such as electrocautery, are commonly used in otolaryngology (ENT) but carry several risks2:

Risk of burns from improper placement

Conductive pathways created by blood or sweat, increasing burn risk

Pressure injuries and skin folds from incorrect patient positioning

Inconsistent results in tight or anatomically complex spaces

These limitations highlight the need for safer and more adaptable topical haemostats. To address this, Surgi-ORC®, offers a safe and cost-effective solution for achieving reliable haemostasis during otorhinolaryngological surgeries.

What is Surgi-ORC®?

Surgi-ORC® is a natural, plant-based absorbable haemostat made from oxidized regenerated cellulose (ORC). It is designed to fix the shortcomings of traditional ORC materials and is biocompatible, fast-acting, bactericidal, easily cut, flexible, suturable, and usable dry around bleeding sites.

Surgi-ORC® Variants for ENT Procedures:

Surgi-ORC® is available in Knit, Original/Standard, and Powder forms to meet diverse procedural needs.

Clinical Evidence

The study evaluated Surgi-ORC® Knit in four ENT surgeries: Parotidectomy, Thyroidectomy, Neck mass excision and Submandibular gland excision. All cases experienced moderate intraoperative bleeding with Surgi-ORC® applied directly to the bleeding site for effective control. On follow-up day 60, no of infections, adhesions, granuloma formation, or foreign body reactions were observed.3

CT Scan Findings3:

Day of application: Surgi-ORC® material visible at the operated sinus site Day 2: Material complete absorbed/degraded

Key Findings:3

Time to Haemostasis: 0.93–2.1 minutes

Absorption: Complete in all cases by Day 28

Adverse events /Complications: None observed

Surgeon feedback: Rated “good” to “excellent” for handling

Conclusion: